Veradigm (STU:AL21) Other Current Receivables: €53.4 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AL21 Veradigm Inc STU:AL21
26 GF Score
Price €3.40
View Full Analysis

What is Veradigm Other Current Receivables?

Veradigm STU:AL21 26 Other Current Receivables is €53.4 Mil as of Dec. 2022. GuruFocus rates STU:AL21 with a GF Score™ of 26/100.

Veradigm's Other Current Receivables for the quarter that ended in Dec. 2022 was €53.4 Mil.

Veradigm's quarterly Other Current Receivables declined from Dec. 2020 (€108.62 Mil) to Dec. 2021 (€57.67 Mil) but then stayed the same from Dec. 2021 (€57.67 Mil) to Dec. 2022 (€53.40 Mil).

Veradigm's annual Other Current Receivables declined from Dec. 2020 (€108.62 Mil) to Dec. 2021 (€57.67 Mil) and declined from Dec. 2021 (€57.67 Mil) to Dec. 2022 (€53.40 Mil).

Veradigm Other Current Receivables Related Terms

Veradigm Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Veradigm's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veradigm Other Current Receivables Chart

Veradigm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.96 108.62 57.67 53.40 86.81

Veradigm Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 May09 May10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.96 108.62 57.67 53.40 86.81
STU:AL21
26GF Score
Veradigm Inc STU:AL21
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veradigm Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €53.4 Mil mean?
Veradigm (STU:AL21) has a Other Current Receivables of €53.4 Mil as of Dec. 2022. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Veradigm and its competitors.
Is Veradigm's Other Current Receivables too high?
Veradigm's current Other Current Receivables is €53.4 Mil. Overall, Veradigm has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Veradigm's Other Current Receivables compare to WEAV and PHR?
Veradigm's Other Current Receivables of €53.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Veradigm and its competitors. Veradigm's current Other Current Receivables is €53.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradigm stock overvalued right now?
Veradigm (STU:AL21) has a current Other Current Receivables of €53.4 Mil. The current Other Current Receivables is €53.4 Mil. Veradigm's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Veradigm (STU:AL21), the current Other Current Receivables is €53.4 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veradigm Business Description

Other Exchanges MDRX:USA
Address 222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654
Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.
26GF Score

Get the complete analysis for STU:AL21

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.40
Price